Every year the World Health Organization (WHO) celebrates World Health Day on April 7th and takes the opportunity to draw attention to a specific...

Biomeme recently announced the completed acquisition of Predigen. The announcement brings together Predigen's combined decades of host response...

New Year, New Biomeme Headquarters

We are settled in and so glad to finally welcome our employees, customers, and everyone involved with Biomeme's...

FIND, the global alliance for diagnostics, announced on December 20, 2021 a US$21 million investment to accelerate the development, manufacturing,...

Biomeme is excited to announce that we have signed a definitive agreement to acquire Predigen, a spin-out from Duke University and global leader in...

Biomeme’s move into its new corporate headquarters at Netrality's 401 North Broad Street, will begin an exciting new chapter for our company.  

We are pleased to announce that the U.S. Food and Drug Administration (FDA) amended Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use...

This is a very common question, so let’s get straight to it.

EDIT: As RNA viruses like SARS-CoV-2 continue to mutate, so will this panel. Please review our COVID-19 page for the latest information regarding our...